Philip T. Edeen

A quantitative analysis of kinase inhibitor selectivity

Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

A small molecule–kinase interaction map for clinical kinase inhibitors

Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +12

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

Todd A. Carter, Lisa Wodicka, Neil P. Shah et al. · Proceedings of the National Academy of Sciences · 2005 · 555 citations · Full text

Medicine, Oncology, Pharmacology +14

Identification and characterization of DAlk: a novel <i>Drosophila melanogaster</i> RTK which drives ERK activation <i>in vivo</i>

Christina E. Lorén, Audra L. Scully, Caroline Grabbe et al. · Genes to Cells · 2001 · 117 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

<i>blue cheese</i>Mutations Define a Novel, Conserved Gene Involved in Progressive Neural Degeneration

Kim D. Finley, Philip T. Edeen, Robert C. Cumming et al. · Journal of Neuroscience · 2003 · 114 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17